Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
- PMID: 23702172
- PMCID: PMC3746796
- DOI: 10.1016/j.ccm.2013.02.003
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
Abstract
Tuberculosis (TB) is the leading cause of opportunistic infection and mortality among HIV-infected persons. Screening for symptoms of TB in people with HIV infection, use of isoniazid preventive therapy for those with latent TB infection, earlier diagnosis and treatment of active TB disease, and early initiation of antiretroviral therapy are essential for controlling the spread of TB. Treatment of HIV-related TB is complicated by overlapping drug toxicities and drug-drug interactions between antiretroviral therapy and anti-TB therapy and risk for development of immune reconstitution inflammatory disease. This review provides an overview of the prevention and treatment of TB in HIV-infected persons.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
HIV infection-related tuberculosis: clinical manifestations and treatment.Clin Infect Dis. 2010 May 15;50 Suppl 3:S223-30. doi: 10.1086/651495. Clin Infect Dis. 2010. PMID: 20397952 Review.
-
The diagnosis, management and prevention of HIV-associated tuberculosis.S Afr Med J. 2014 Dec;104(12):886-93. doi: 10.7196/samj.9090. S Afr Med J. 2014. PMID: 26042273 Review.
-
Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.Ann Intern Med. 2014 Sep 16;161(6):JC12. doi: 10.7326/0003-4819-161-6-201409160-02012. Ann Intern Med. 2014. PMID: 25222412 No abstract available.
-
Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.MMWR Recomm Rep. 1998 Oct 30;47(RR-20):1-58. MMWR Recomm Rep. 1998. PMID: 9809743
-
Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis.Viruses. 2024 Mar 23;16(4):494. doi: 10.3390/v16040494. Viruses. 2024. PMID: 38675837 Free PMC article. Review.
Cited by
-
Clinical Correlates and Drug Resistance in HIV-Infected and -Uninfected Pulmonary Tuberculosis Patients in South India.World J AIDS. 2016 Sep;6(3):87-100. doi: 10.4236/wja.2016.63013. Epub 2016 Sep 9. World J AIDS. 2016. PMID: 27708985 Free PMC article.
-
Economic challenges associated with tuberculosis diagnostic development.Expert Rev Pharmacoecon Outcomes Res. 2014 Aug;14(4):499-510. doi: 10.1586/14737167.2014.914438. Epub 2014 Apr 28. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24766367 Free PMC article. Review.
-
A pilot study to determine the occurrence of concomitant diseases and drug intake in patients on antituberculosis therapy.J Family Med Prim Care. 2018 Mar-Apr;7(2):414-419. doi: 10.4103/jfmpc.jfmpc_103_17. J Family Med Prim Care. 2018. PMID: 30090786 Free PMC article.
-
Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS.Biomed Res Int. 2014;2014:294963. doi: 10.1155/2014/294963. Epub 2014 May 29. Biomed Res Int. 2014. PMID: 24991546 Free PMC article.
-
BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.Clin Dev Immunol. 2013;2013:721383. doi: 10.1155/2013/721383. Epub 2013 Oct 29. Clin Dev Immunol. 2013. PMID: 24288555 Free PMC article.
References
-
- Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57–72. - PubMed
-
- WHO. [Accessed 12/29/2012];global tuberculosis report. 2012 http://www.who.int/tb/publications/global_report/en/
-
- Blumberg HM, Burman WJ, Chaisson RE, et al. American thoracic society/centers for disease control and prevention/infectious diseases society of america: Treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–662. - PubMed
-
- Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the national institutes of health, and the HIV medicine association of the infectious diseases society of america. MMWR Recomm Rep. 2009;58(RR-4):1–207. quiz CE1-4. - PubMed
-
- Bassett IV, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in durban, south africa. Clin Infect Dis. 2010 www.refworks.com. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical